OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
How to use COVID-19 antiviral drugs in patients with chronic kidney disease
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Showing 20 citing articles:
Effectiveness and safety of azvudine in older adults with mild and moderate COVID-19: a retrospective observational study
Zhiguo Zhou, He Zheng, Gui’e Xiao, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Zhiguo Zhou, He Zheng, Gui’e Xiao, et al.
BMC Infectious Diseases (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 5
Clinical implications of COVID-19 in chronic kidney disease and end-stage kidney disease
Paul Cockwell, Matthew D. Griffin
Elsevier eBooks (2025), pp. 543-568
Closed Access
Paul Cockwell, Matthew D. Griffin
Elsevier eBooks (2025), pp. 543-568
Closed Access
Kidney failure-related excess mortality during the first three years of the COVID-19 pandemic in the United States: a nation-wide, population-based analysis
Zhenhu Chen, Pingping Jia, Di Xie, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Zhenhu Chen, Pingping Jia, Di Xie, et al.
BMC Public Health (2025) Vol. 25, Iss. 1
Open Access
Impact of COVID-19 on preexisting comorbidities
Rasha Ashmawy, Esraa Abdellatif Hamouda, Sally Zeina, et al.
Progress in molecular biology and translational science (2025)
Closed Access
Rasha Ashmawy, Esraa Abdellatif Hamouda, Sally Zeina, et al.
Progress in molecular biology and translational science (2025)
Closed Access
Antiviral effectiveness and safety of azvudine in hospitalized SARS‐CoV‐2 patients with pre‐existing chronic respiratory diseases: A multicenter, retrospective cohort study
Junyi Sun, Mengzhao Yang, Daoke Yao, et al.
View (2025)
Open Access
Junyi Sun, Mengzhao Yang, Daoke Yao, et al.
View (2025)
Open Access
Therapeutic Management of Ebola Virus: Targeting Oxidative Stress and Inflammatory Pathways
Martin Ndayambaje, Hicham Wahnou, Abdallah Naya, et al.
BioChem (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Martin Ndayambaje, Hicham Wahnou, Abdallah Naya, et al.
BioChem (2025) Vol. 5, Iss. 1, pp. 3-3
Open Access
Comparison of azvudine, molnupiravir, and nirmatrelvir/ritonavir in adult patients with mild-to-moderate COVID-19: a retrospective cohort study
Meiping Chen, Dixuan Jiang, Jiaxi Rang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Meiping Chen, Dixuan Jiang, Jiaxi Rang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Population Pharmacokinetics of Nirmatrelvir in Chinese Patients with COVID-19: Therapeutic Drug Monitoring and Dosing Regimen Selection in Clinical Practice
Ping Yang, Wei Liu, Yingqiu Ying, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 2, pp. 107199-107199
Closed Access | Times Cited: 2
Ping Yang, Wei Liu, Yingqiu Ying, et al.
International Journal of Antimicrobial Agents (2024) Vol. 64, Iss. 2, pp. 107199-107199
Closed Access | Times Cited: 2
The pharmacists’ interventions after a Drug and Therapeutics Committee (DTC) establishment during the COVID-19 pandemic
Amira B. Kassem, Ahmad Z. Al Meslamani, Dina H. Elmaghraby, et al.
Journal of Pharmaceutical Policy and Practice (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Amira B. Kassem, Ahmad Z. Al Meslamani, Dina H. Elmaghraby, et al.
Journal of Pharmaceutical Policy and Practice (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Risk factors and prognosis for coronavirus disease 2019 among 131 hemodialysis patients during the Omicron variant epidemic
Wen Wen, Shiming Cai, Yuehong Li, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 7
Wen Wen, Shiming Cai, Yuehong Li, et al.
Renal Failure (2023) Vol. 45, Iss. 1
Open Access | Times Cited: 7
Effectiveness of Molnupiravir and Nirmatrelvir-Ritonavir in CKD Patients With COVID-19
Franco Wing Tak Cheng, Vincent Ka Chun Yan, Eric Yuk Fai Wan, et al.
Kidney International Reports (2024) Vol. 9, Iss. 5, pp. 1244-1253
Open Access | Times Cited: 1
Franco Wing Tak Cheng, Vincent Ka Chun Yan, Eric Yuk Fai Wan, et al.
Kidney International Reports (2024) Vol. 9, Iss. 5, pp. 1244-1253
Open Access | Times Cited: 1
Pharmacokinetics of nirmatrelvir/ritonavir and the drug-drug interaction with calcineurin inhibitor in renal transplant recipients
Xueyin Xu, Huanxi Zhang, Longshan Liu, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 8, pp. 1219-1227
Closed Access | Times Cited: 1
Xueyin Xu, Huanxi Zhang, Longshan Liu, et al.
European Journal of Clinical Pharmacology (2024) Vol. 80, Iss. 8, pp. 1219-1227
Closed Access | Times Cited: 1
Effectiveness and Optimal Timing of Azvudine in COVID-19 Patients: A Multi-center Retrospective Study in Beijing, China
Xinjie Han, Han Xiao-bo, Yongqian Wang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Xinjie Han, Han Xiao-bo, Yongqian Wang, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 4
Kidney Issues Associated with COVID-19 Disease
Periklis Dousdampanis, Αthanasia Mouzaki, Konstantina Trigka, et al.
Encyclopedia (2023) Vol. 3, Iss. 3, pp. 1085-1104
Open Access | Times Cited: 3
Periklis Dousdampanis, Αthanasia Mouzaki, Konstantina Trigka, et al.
Encyclopedia (2023) Vol. 3, Iss. 3, pp. 1085-1104
Open Access | Times Cited: 3
Repurposing existing drugs for the treatment ofCOVID-19/SARS-CoV-2: A review of pharmacological effects and mechanism of action
Yutong Liang, Xiaoxiao Quan, Ruolan Gu, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35988-e35988
Closed Access
Yutong Liang, Xiaoxiao Quan, Ruolan Gu, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35988-e35988
Closed Access
Acute Kidney Injury Incidence in COVID-19 Patients Receiving Remdesivir Therapy at Awal Bros Panam Hospital
Ade Novita Reslina, Faradilla Monita, Ligat Pribadi Sembiring
Indonesian Journal of Kidney and Hypertension (2024) Vol. 1, Iss. 2, pp. 12-19
Open Access
Ade Novita Reslina, Faradilla Monita, Ligat Pribadi Sembiring
Indonesian Journal of Kidney and Hypertension (2024) Vol. 1, Iss. 2, pp. 12-19
Open Access
Population pharmacokinetics of nirmatrelvir/ritonavir in critically ill Chinese COVID-19 patients and recommendations for medication use: a two-center retrospective study
Junjun Xu, Jinmeng Li, Meng Chen, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1071-1079
Closed Access
Junjun Xu, Jinmeng Li, Meng Chen, et al.
Expert Review of Clinical Pharmacology (2024) Vol. 17, Iss. 11, pp. 1071-1079
Closed Access
The effect of combination treatment with casirivimab and imdevimab versus standard antiviral therapy on clinical outcomes in hospitalized COVID-19 patients
Sahar K. Hegazy, Ahmed H. Hassan
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Sahar K. Hegazy, Ahmed H. Hassan
Deleted Journal (2024) Vol. 1, Iss. 1
Open Access
Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A Retrospective Study
Wei Yang, Weiting Zhang, Jing Zhou, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 12, pp. 102583-102583
Open Access
Wei Yang, Weiting Zhang, Jing Zhou, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 12, pp. 102583-102583
Open Access
